NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 14 04:00PM ET
2.29
Dollar change
+0.07
Percentage change
3.15
%
Index- P/E- EPS (ttm)-0.54 Insider Own70.20% Shs Outstand36.19M Perf Week12.25%
Market Cap82.88M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.79M Perf Month12.25%
Enterprise Value205.85M PEG- EPS next Q-0.39 Inst Own2.05% Short Float0.96% Perf Quarter141.05%
Income-0.43M P/S17.63 EPS this Y-117.98% Inst Trans-46.04% Short Ratio0.41 Perf Half Y10.63%
Sales4.70M P/B- EPS next Y- ROA-0.41% Short Interest0.10M Perf YTD23.78%
Book/sh-1.49 P/C7.09 EPS next 5Y- ROE- 52W High3.42 -32.95% Perf Year-19.65%
Cash/sh0.32 P/FCF- EPS past 3/5Y18.34% 26.80% ROIC- 52W Low0.90 154.98% Perf 3Y-41.88%
Dividend Est.- EV/EBITDA- Sales past 3/5Y4.96% - Gross Margin70.80% Volatility8.59% 8.23% Perf 5Y-45.48%
Dividend TTM- EV/Sales43.80 EPS Y/Y TTM99.47% Oper. Margin-859.76% ATR (14)0.17 Perf 10Y-99.84%
Dividend Ex-Date- Quick Ratio0.12 Sales Y/Y TTM0.00% Profit Margin-9.07% RSI (14)63.00 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.12 EPS Q/Q73.94% SMA2013.82% Beta0.98 Target Price9.00
Payout- Debt/Eq- Sales Q/Q-49.17% SMA5023.27% Rel Volume0.05 Prev Close2.22
Employees60 LT Debt/Eq- EarningsMay 14 AMC SMA20015.94% Avg Volume255.47K Price2.29
IPOMay 20, 1994 Option/ShortYes / Yes EPS/Sales Surpr.47.37% -64.42% Trades Volume12,087 Change3.15%
Date Action Analyst Rating Change Price Target Change
Jun-19-19Initiated Ladenburg Thalmann Buy $9
May-21-25 09:50AM
May-19-25 07:00AM
May-14-25 05:45PM
04:05PM
09:10AM
05:55PM Loading…
May-12-25 05:55PM
May-08-25 07:10AM
May-01-25 07:00AM
Apr-28-25 04:53AM
Apr-24-25 06:25AM
Apr-09-25 05:24AM
Mar-20-25 05:56PM
Mar-12-25 05:08PM
Mar-11-25 07:00AM
Dec-20-24 07:15AM
07:00AM Loading…
Dec-19-24 07:00AM
Nov-19-24 07:00AM
Nov-13-24 04:05PM
Nov-12-24 07:00AM
Oct-30-24 07:00AM
Sep-12-24 12:00PM
Sep-05-24 07:30AM
Aug-26-24 07:30AM
Aug-15-24 04:45PM
Aug-13-24 04:05PM
Jul-30-24 07:00AM
Jul-11-24 07:00AM
Jul-10-24 04:05PM
May-07-24 04:01PM
Mar-21-24 04:05PM
04:01PM Loading…
Mar-04-24 04:01PM
Feb-21-24 07:00AM
Nov-14-23 04:00PM
Oct-30-23 08:00AM
Oct-19-23 08:00AM
Sep-26-23 08:00AM
Sep-21-23 07:00AM
Aug-17-23 09:55AM
Aug-14-23 07:00AM
Jul-11-23 08:00AM
May-31-23 08:00AM
May-11-23 04:05PM
Mar-16-23 04:10PM
Mar-06-23 06:00AM
Jan-10-23 04:05PM
Dec-22-22 08:00AM
Dec-08-22 09:55AM
Nov-28-22 09:35AM
08:00AM
Nov-15-22 09:55AM
Nov-09-22 04:15PM
Aug-11-22 04:05PM
Aug-01-22 08:00AM
May-23-22 08:00AM
May-12-22 04:17PM
Mar-31-22 04:05PM
Mar-22-22 10:00AM
Mar-17-22 04:05PM
Mar-09-22 05:28PM
Feb-22-22 08:00AM
Feb-17-22 08:00AM
Feb-09-22 04:16PM
Jan-06-22 08:50AM
Jan-05-22 08:00AM
Nov-29-21 10:00AM
Nov-18-21 08:00AM
Nov-17-21 12:00PM
Nov-10-21 04:05PM
Nov-04-21 03:01PM
08:00AM
Nov-02-21 08:00AM
Oct-28-21 06:41PM
Sep-08-21 08:00AM
Aug-12-21 04:05PM
Aug-05-21 03:00PM
Aug-02-21 07:30AM
Jul-07-21 07:30AM
May-13-21 04:05PM
10:45AM
Mar-18-21 04:05PM
Mar-17-21 04:01PM
Mar-16-21 11:01AM
Jan-27-21 07:01AM
Dec-09-20 07:30AM
Nov-16-20 11:10PM
Nov-15-20 07:17AM
Nov-12-20 04:05PM
Oct-29-20 07:30AM
Oct-26-20 07:30AM
Oct-15-20 07:30AM
Sep-29-20 07:30AM
Sep-11-20 07:30AM
Aug-13-20 04:05PM
Jun-30-20 06:05AM
Jun-17-20 07:30AM
May-14-20 04:05PM
Apr-28-20 08:00AM
Mar-30-20 07:30AM
Mar-19-20 04:05PM
Mar-18-20 08:00AM
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.